Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 電機資訊學院
  3. 資訊工程學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42083
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor張瑞峰(Ruey-Feng Chang)
dc.contributor.authorYung-Hsiang Leien
dc.contributor.author雷詠翔zh_TW
dc.date.accessioned2021-06-15T00:45:44Z-
dc.date.available2008-09-02
dc.date.copyright2008-09-02
dc.date.issued2008
dc.date.submitted2008-08-26
dc.identifier.citation[1] R. Lagalla, G. Caruso, and M. Finazzo, 'Monitoring treatment response with color and power Doppler,' Eur J Radiol, vol. 27 Suppl 2, pp. S149-56, May 1998.
[2] T. Tanvetyanon, J. I. Clark, S. C. Campbell, and S. S. Lo, 'Neoadjuvant therapy: an emerging concept in oncology,' South Med J, vol. 98, pp. 338-44, Mar 2005.
[3] B. D. Fornage, O. Toubas, and M. Morel, 'Clinical, mammographic, and sonographic determination of preoperative breast cancer size,' Cancer, vol. 60, pp. 765-71, Aug 15 1987.
[4] M. A. Helvie, L. K. Joynt, R. L. Cody, L. J. Pierce, D. D. Adler, and S. D. Merajver, 'Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy,' Radiology, vol. 198, pp. 327-32, Feb 1996.
[5] S. J. Vinnicombe, A. D. MacVicar, R. L. Guy, J. P. Sloane, T. J. Powles, G. Knee, and J. E. Husband, 'Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation,' Radiology, vol. 198, pp. 333-40, Feb 1996.
[6] J. Herrada, R. B. Iyer, E. N. Atkinson, N. Sneige, A. U. Buzdar, and G. N. Hortobagyi, 'Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma,' Clin Cancer Res, vol. 3, pp. 1565-9, Sep 1997.
[7] S. Huber, M. Wagner, I. Zuna, M. Medl, H. Czembirek, and S. Delorme, 'Locally advanced breast carcinoma: evaluation of mammography in the prediction of residual disease after induction chemotherapy,' Anticancer Res, vol. 20, pp. 553-8, Jan-Feb 2000.
[8] A. F. Schott, M. A. Roubidoux, M. A. Helvie, D. F. Hayes, C. G. Kleer, L. A. Newman, L. J. Pierce, K. A. Griffith, S. Murray, K. A. Hunt, C. Paramagul, and L. H. Baker, 'Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy,' Breast Cancer Res Treat, vol. 92, pp. 231-8, Aug 2005.
[9] C. Balu-Maestro, C. Chapellier, A. Bleuse, I. Chanalet, C. Chauvel, and R. Largillier, 'Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI,' Breast Cancer Res Treat, vol. 72, pp. 145-52, Mar 2002.
[10] M. A. Roubidoux, G. L. LeCarpentier, J. B. Fowlkes, B. Bartz, D. Pai, S. P. Gordon, A. F. Schott, T. D. Johnson, and P. L. Carson, 'Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy,' J Ultrasound Med, vol. 24, pp. 885-95, Jul 2005.
[11] S. C. Partridge, J. E. Gibbs, Y. Lu, L. J. Esserman, D. Sudilovsky, and N. M. Hylton, 'Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy,' AJR Am J Roentgenol, vol. 179, pp. 1193-9, Nov 2002.
[12] E. L. Rosen, K. L. Blackwell, J. A. Baker, M. S. Soo, R. C. Bentley, D. Yu, T. V. Samulski, and M. W. Dewhirst, 'Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy,' AJR Am J Roentgenol, vol. 181, pp. 1275-82, Nov 2003.
[13] F. Thibault, C. Nos, M. Meunier, C. El Khoury, L. Ollivier, B. Sigal-Zafrani, and K. Clough, 'MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy,' AJR Am J Roentgenol, vol. 183, pp. 1159-68, Oct 2004.
[14] M. Schelling, N. Avril, J. Nahrig, W. Kuhn, W. Romer, D. Sattler, M. Werner, J. Dose, F. Janicke, H. Graeff, and M. Schwaiger, 'Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer,' J Clin Oncol, vol. 18, pp. 1689-95, Apr 2000.
[15] R. Tiling, R. Linke, M. Untch, A. Richter, S. Fieber, K. Brinkbaumer, K. Tatsch, and K. Hahn, '18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study,' Eur J Nucl Med, vol. 28, pp. 711-20, Jun 2001.
[16] C. K. Kuhl, 'The 'coming of age' of nonmammographic screening for breast cancer,' Jama-Journal of the American Medical Association, vol. 299, pp. 2203-2205, May 14 2008.
[17] W. A. Berg, J. D. Blume, J. B. Cormack, E. B. Mendelson, D. Lehrer, M. Bohm-Velez, E. D. Pisano, R. A. Jong, W. P. Evans, M. J. Morton, M. C. Mahoney, L. H. Larsen, R. G. Barr, D. M. Farria, H. S. Marques, K. Boparai, and A. Investigators, 'Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer,' Jama-Journal of the American Medical Association, vol. 299, pp. 2151-2163, May 14 2008.
[18] H. Madjar, H. J. Prompeler, W. Sauerbrei, A. Mundinger, and A. Pfleiderer, 'Differential-Diagnosis of Breast-Lesions by Color Doppler,' Ultrasound in Obstetrics & Gynecology, vol. 6, pp. 199-204, Sep 1995.
[19] W. J. Lee, J. S. Chu, C. S. Huang, M. F. Chang, K. J. Chang, and K. M. Chen, 'Breast cancer vascularity: Color Doppler sonography and histopathology study,' Breast Cancer Research and Treatment, vol. 37, pp. 291-298, 1996.
[20] G. M. Giuseppetti, S. Baldassarre, and E. Marconi, 'Color Doppler sonography,' European Journal of Radiology, vol. 27, pp. S254-S258, May 1998.
[21] G. Rizzatto and R. Chersevani, 'Breast ultrasound and new technologies,' European Journal of Radiology, vol. 27, pp. S242-S249, May 1998.
[22] T. C. Chao, Y. F. Lo, S. C. Chen, and M. F. Chen, 'Color Doppler ultrasound in benign and malignant breast tumors,' Breast Cancer Research and Treatment, vol. 57, pp. 193-199, Sep 1999.
[23] S. F. Huang, R. F. Chang, W. K. Moon, Y. H. Lee, D. R. Chen, and J. S. Suri, 'Analysis of tumor vascularity using three-dimensional power Doppler ultrasound images,' Ieee Transactions on Medical Imaging, vol. 27, pp. 320-330, Mar 2008.
[24] R. F. Chang, S. F. Huang, W. K. Moon, Y. H. Lee, and D. R. Chen, 'Solid breast masses: Neural network analysis of vascular features at three-dimensional power Doppler US for benign or malignant classification,' Radiology, vol. 243, pp. 56-62, Apr 2007.
[25] H. Ohkura, 'Tumor markers in monitoring response to chemotherapy for patients with gastric cancer,' Japanese Journal of Clinical Oncology, vol. 29, pp. 525-526, Nov 1999.
[26] K. Palagyi and A. Kuba, 'A 3D 6-subiteration thinning algorithm for extracting medial lines,' Pattern Recognition Letters, vol. 19, pp. 613-627, May 1998.
[27] W. H. Kuo, C. N. Chen, F. J. Hsieh, M. K. Shyu, L. Y. Chang, P. H. Lee, L. Y. Liu, C. H. Cheng, J. Wang, and K. J. Chang, 'Vascularity change and tumor response to neoadjuvant chemotherapy for advanced breast cancer,' Ultrasound Med Biol, vol. 34, pp. 857-66, Jun 2008.
[28] P. Perona and J. Malik, 'Scale-Space and Edge-Detection Using Anisotropic Diffusion,' Ieee Transactions on Pattern Analysis and Machine Intelligence, vol. 12, pp. 629-639, Jul 1990.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42083-
dc.description.abstract乳房X光片、超音波、以及磁振造影等技術,常被用來檢視乳癌對於化學治療的反應效果。在本篇論文中,是採用三維的都普勒(Doppler)超音波影像來評估血管對於化學治療的反應。傳統的血管評估方法為血管指標(vascularity index, VI),但是此方法在本實驗中無法為血管影像提供良好的再現性(reproducibility),這主要是由於血管影像會因為病人的心跳以及呼吸等影響,而在影像中產生雜訊。因此,我們在本篇論文中提出了一個基於血管長度的評估方法,此方法可以去除影像中不必要的雜訊。首先,對於血管影像使用三維的細化演算法,以取出血管的主要骨架,並且計算血管的長度。為了要去除雜訊造成的影響,我們提出一個新的雜訊移除演算法。再此雜訊移除演算法中,我們先定出一個半徑門檻值。對於所有的血管,只有半徑大於此門檻值的才會計算其長度。在相對值雜訊移除演算法中,百分之二十和百分之十所得到的再現性分別為0.075和0.078。而在固定值演算法中,五像素和三像素所得到的結果分別為0.119和0.097。相對值演算法會比固定值演算法得到更好的結果。另外,我們則是利用血管長度的變化量,來評估一個病人對於接受化學治療後的反應。我們發現,利用百分之二十所得到的結果比百分之十的結果還要差。因此我們認為,百分之十的相對值演算法比較適合對化學治療的反應作評估。zh_TW
dc.description.abstractSeveral imaging modalities such as mammography, ultrasound (US), and magnetic resonance imaging (MRI) have been applied to evaluating the therapeutic response of neoadjuvant therapy for breast cancer. In this paper, the three-dimensional (3-D) Doppler US is adopted for evaluating the vascularity. The conventional vascularity index (VI) method is usually used to evaluate the vascularity. From our experiments, this method could not have enough reproducibility for monitoring the chemotherapy response due to the artificial vessel noise by breath and heartbeat. Hence, a new vascularity evaluation method based on the vessel length is proposed to reduce the vessel noise in this paper. At first, the 3-D thinning algorithm for the vessel image is performed to extract the vessel skeleton and then the vessel lengths could be found from the skeleton as the vascularity. Nevertheless, this proposed vessel length information still does not have enough reproducibility due to the vessel noise. In order to improve the vessel reproducibility, a vessel noise reduction method is developed to analyze the vessel lengths. In the proposed noise reduction method, only the lengths of vessels larger than a threshold are counted. The threshold could be a fixed value or proportion to the maximum vessel radius. In the relative noise reduction method, the average reproducibilities of 20% and 10% reductions are 0.075 and 0.078 in our cases. The reproducibility of fixed threshold reduction by 5-pixel and 3-pixel are 0.119 and 0.097 respectively. The relative threshold reductions have better performance than the fixed threshold reductions. Furthermore, the response during the chemotherapy for a patient could also be evaluated by the changes of vessel lengths. The therapy evaluation result of 20% reduction is worse than that of 10% reduction. Therefore, we conclude that the 10% noise reduction method is a better evaluation method for the response of chemotherapy.en
dc.description.provenanceMade available in DSpace on 2021-06-15T00:45:44Z (GMT). No. of bitstreams: 1
ntu-97-R95922087-1.pdf: 2371583 bytes, checksum: 05e55230e557561c6a39db655c6f562f (MD5)
Previous issue date: 2008
en
dc.description.tableofcontentsChapter 1 1
Chapter 2 Background 4
Chapter 3 The Proposed Chemotherapy Response Evaluation System 7
3.2 3-D Thinning Algorithm for Vessel Skeleton 9
3.2.1 Vessel Pixel Extraction 9
3.2.2 Vessel Skeleton Extraction 10
3.3 Vessel Noise Reduction 12
Chapter 4 Experiments and Results 14
4.1 Experimental Results 14
4.1.1 Reproducibility analysis 14
4.1.2 Therapy analysis 25
4.1.3 Discussion 30
Chapter 5 Conclusion 33
References 35
dc.language.isoen
dc.subject雜訊去除演算法zh_TW
dc.subjectnoise reduction methoden
dc.title利用3-D彩色超音波的乳房腫瘤化學治療反應評估zh_TW
dc.titleBreast Cancer Chemotherapy Response Evaluation Using 3-D Power Doppler Ultrasounden
dc.typeThesis
dc.date.schoolyear96-2
dc.description.degree碩士
dc.contributor.oralexamcommittee陳偉銘,陳啟禎
dc.subject.keyword雜訊去除演算法,zh_TW
dc.subject.keywordnoise reduction method,en
dc.relation.page38
dc.rights.note有償授權
dc.date.accepted2008-08-26
dc.contributor.author-college電機資訊學院zh_TW
dc.contributor.author-dept資訊工程學研究所zh_TW
顯示於系所單位:資訊工程學系

文件中的檔案:
檔案 大小格式 
ntu-97-1.pdf
  未授權公開取用
2.32 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved